Contemporary surgical management of HIV-associated facial lipoatrophy.
OBJECTIVE
The purpose of this study is to describe our experience with facial volume restoration in 39 HIV-associated facial lipoatrophy patients, and formulate a treatment algorithm that can be utilized for these patients based on their disease severity.


METHODS
Preoperative and postoperative photographs were evaluated by 2 experienced facial plastic surgeons using grading scales. The reviewers' scores were then compared and the distribution of scores was analyzed.


RESULTS
Thirty-nine patients underwent malar silastic implantation. Seven patients required postoperative adjuvant filler injection. Most patients' results were rated good to excellent. There were 4 late complications.


CONCLUSIONS
HIV-associated facial lipoatrophy is a socially disabling condition that causes noticeable disfigurement and stigmatizes the patient. We demonstrate the importance of combining a reliable grading scale with a strategic treatment algorithm that utilizes multiple modalities for volume restoration.


METHODS
C-4.
Funk
E
E
Bobby R. Alford Department of Otolaryngology/Head and Neck Surgery and Communicative Sciences, Baylor College of Medicine, Houston, Texas 77030, USA. etaif@bcm.tmc.edu
Bressler
F J
FJ
Brissett
A E
AE
D000273:Adipose Tissue / Q000473:pathology*; D000328:Adult; D001284:Atrophy; D001672:Biocompatible Materials; D004129:Dimethylpolysiloxanes; D005145:Face / Q000473:pathology / Q000601:surgery*; D005260:Female; D015658:HIV Infections / Q000150:complications*; D039682:HIV-Associated Lipodystrophy Syndrome / Q000601:surgery*; D006801:Humans; D008297:Male; D008875:Middle Aged; D019736:Prostheses and Implants; D012828:Silicones; D013518:Surgery, Plastic / Q000379:methods*; D016896:Treatment Outcome
D001672:Biocompatible Materials; D004129:Dimethylpolysiloxanes; D012828:Silicones; C013830:baysilon